Homebiotech

biotech

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial

Jim Cornall - December 22, 2025

biotech

Platform to test new cancer treatments

Jim Cornall - December 22, 2025

biotech

Potential biomarker for targeted psoriasis therapy discovered

Jim Cornall - December 22, 2025

biotech

Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin

Jim Cornall - December 19, 2025

biotech

Sobi boosts gout battle with Arthrosi Therapeutics acquisition

Jim Cornall - December 18, 2025

biotech

Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis

Jim Cornall - December 18, 2025

biotech

InnoCare to move to phase 3 after achieving SLE endpoints

Jim Cornall - December 18, 2025

biotech

First precision therapy prostate cancer drug approved

Jim Cornall - December 17, 2025

1...323334...78 Page 33 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026 0

Avaí Bio, Inc., an emerging biotechnology company developing cell-based therapies for diabetes, age-related disorders, and anti-aging, has announced - together with its joint venture...

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0